Partner Vinay Navani, and host Chris Frederick, kick off Season 3 with an episode discussing the key obstacles businesses may face when looking to…
Vinay NavaniJanuary 2, 2024
Collaboration agreements are often seen as a means for life sciences, biotechnology, and other companies to share the risks often…
Tim TorresDecember 5, 2023
Today’s economy is strife with soaring costs, and every business feels the impact. Look no further than development-stage life science…
Tim TorresNovember 30, 2023
Life science companies enter into different types of contractual agreements, and each type has its own characteristics when it comes…
Tim TorresNovember 15, 2023
For pharmaceutical companies that aim to improve cash flow while serving the public good, Internal Revenue Code (IRC) 170(e)(3) provides…
Tim TorresSeptember 8, 2023
Chargebacks previously explained in our article titled, “What Are Chargebacks, and Why Are They Important?” are contracts between wholesale customers…
Tim TorresSeptember 8, 2023
The Federal tax law changes surrounding research and development (R&D) expenses (Internal Revenue Code Section 174), which became effective January…
Tim TorresJuly 18, 2023
Recently we’ve encountered a unique situation highlighting the importance of analyzing the underlying agreements and transactions under the lens of…
Tim TorresJune 23, 2023
New Jersey Programs Promoting Investments in Life-Sciences and Technology Businesses The state of New Jersey has made its intention to…
Tim TorresJune 22, 2023
